ArticleAmerican journal of hematology2009
Enzyme replacement therapy for mild patients with Gaucher disease.
Article in American journal of hematology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 28 citations in OpenAlex.
- Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry.Journal of clinical medicine · 2024Article
- A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy.Journal of clinical medicine · 2024Article
- Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher Disease.Journal of clinical medicine · 2019Article
- β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems.Frontiers in immunology · 2019Review
- Gaucher's disease and cancer: a sphingolipid perspective.Critical reviews in oncogenesis · 2013Review
- Imiglucerase in the treatment of Gaucher disease: a history and perspective.Drug design, development and therapy · 2012Review
- Gaucher disease and cancer: concept and controversy.International journal of cell biology · 2011Article
- Generation of polyclonal antibodies against recombinant human glucocerebrosidase produced in Escherichia coli.Molecular biotechnology · 2010Article
- Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy.Journal of inherited metabolic disease · 2010Article
- Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?Clinical and experimental immunology · 2009Article
- Gaucher disease: resetting the clinical and scientific agenda.American journal of hematology · 2009Article
- Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.Biologics : targets & therapy · 2009Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.